Citius Pharmaceuticals, Inc. CTXR
0.51 USD -0.02 (-3.35%)
As ofNov 17, 2026, 3:23 PM EST
0.503 Day range 0.5396
0.37 52-week range 1.54
- YTD
- -34.38%
- 1 year
- -45.47%
News
prnewswire.com Citius Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London Chairman and CEO Leonard Mazur to host one-on-one business development meetings CRANFORD, N.J., Nov. 11, 2026 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq:…benzinga.com Citius Oncology Reports Preliminary Q4 FY2026 LYMPHIR Wholesaler Unit Sales More Than Doubling 120% To 792 Units, With 950 Institutional Vial Orders And 54 Institutions Ordering The CTCL Treatment itius Oncology, Inc. ("Citius Oncology" or the "Company") (NASDAQ:CTOR), an oncology-focused biopharmaceutical company and majority-owned subsidiary of Citius Pharmaceuticals, Inc. ("Citius
